ONE Bio Corp.

Total Valuation

ONE Bio Corp. carries a market capitalization of 4,236.00, placing it among publicly traded companies globally. Its enterprise value stands at 46.23M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

ONE Bio Corp. currently has 8.47M shares outstanding.

Valuation Ratios

ONE Bio Corp. trades at a trailing price-to-earnings ratio of 3.64. The price-to-sales ratio is 0.63, and the price-to-book ratio stands at 1.47.

Enterprise Valuation

On an enterprise value basis, ONE Bio Corp. trades at an EV/EBITDA multiple of 3.29 and an EV/FCF ratio of 2.66. The EV/Sales ratio of 0.86 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.12 provides insight into valuation relative to core operating earnings.

Financial Position

ONE Bio Corp. maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 52.79, indicating elevated leverage, while an interest coverage ratio of 10.55 demonstrates strong ability to service its debt obligations.

Financial Efficiency

ONE Bio Corp. posts a return on equity of 46.49 and a return on invested capital of 15.49.

Taxes

Over the trailing twelve months, ONE Bio Corp. has paid 3.90M in income taxes, reflecting an effective tax rate of 29.35.

Stock Price Statistics

ONE Bio Corp.'s stock has gained approximately 150.00001% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Income Statement

Over the trailing twelve months, ONE Bio Corp. generated 53.91M in revenue and converted that into 9.36M in net income, yielding earnings per share of 1.24. EBITDA reached 14.05M, while operating income came in at 14.83M.

Balance Sheet

ONE Bio Corp. holds 14.46M in cash and equivalents against 26.02M in total debt, resulting in a net debt position of 11.56M. Total book value stands at 23.23M, with working capital of 18.15M providing operational flexibility.

Cash Flow

ONE Bio Corp. produced 11.87M in operating cash flow over the past twelve months. After subtracting -4.57M in capital expenditures, free cash flow totaled 7.30M - equivalent to 1.03 per share.

Margins

ONE Bio Corp. operates with a gross margin of 43.90, reflecting its pricing power and cost economics. The operating margin of 27.50 and net profit margin of 17.36 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

ONE Bio Corp.'s most recent stock split took place on September 15, 2010 with a 5:1 split ratio.

Scores

ONE Bio Corp. posts an Altman Z-Score of 2.54, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.